Market Alert : Can the ASX 200 Maintain Its Upward Momentum Through Earnings Season?

3 ASX Stocks Surge as Major Corporate Developments Capture Investor Attention

3 ASX Stocks Surge as Major Corporate Developments Capture Investor Attention Source: Kapitales Research

Highlights:

  • Lycopodium delivered FY26 revenue growth and issued ambitious FY27 guidance, pointing to a substantial increase in earnings.
  • Macmahon disclosed the conversion of 192,250 share rights into ordinary shares under its Non-Executive Director Salary Sacrifice Plan.
  • European Lithium amended its proposed merger terms with Critical Metals Corp., potentially increasing the number of CRML shares received by EUR shareholders.

Stocks in Focus

The resources sector attracted strong investor attention on 19 August 2026, with Lycopodium Limited (ASX: LYL), Macmahon Holdings Limited (ASX: MAH) and European Lithium Limited (ASX: EUR) recording sharp share price gains. The three announcements highlighted different developments across engineering services, mining operations and critical minerals, creating renewed market interest.

Lycopodium Builds a Stronger FY27 Outlook

Lycopodium Limited jumped 13.443% to AU$21.350 after delivering FY26 results and outlining a significantly stronger outlook. Revenue increased to AU$377.5 million, compared with AU$339.6 million in FY25, while EBITDA stood at AU$59.5 million and NPAT reached AU$40.2 million.

The bigger focus is FY27, with management guiding for revenue between AU$540 million and AU$580 million and NPAT of AU$54 million to AU$58 million. At the midpoint, the guidance implies approximately 50% revenue growth and 40% NPAT growth. Lycopodium said demand remains supported by gold, critical minerals, uranium and infrastructure, while recent project wins are strengthening its secured pipeline.

Macmahon Signals Director Shareholding Changes

Macmahon Holdings Limited gained 12.707% to AU$1.020. The available 19 August announcement concerns securities issued following the vesting of share rights rather than an operating or financial result.

A total of 192,250 ordinary shares were issued following the conversion of vested share rights under the Non-Executive Director Salary Sacrifice Plan. Of this amount, 64,100 shares related to director Greg Evans and 128,150 to director Dharmendra Chandran.

European Lithium Reshapes Merger Terms

European Lithium Limited advanced 12.068% to AU$0.325 after announcing revised terms for its proposed combination with NASDAQ-listed Critical Metals Corp.The revised agreement replaces the previous fixed exchange ratio with a floating mechanism capped between 0.025 and 0.045 CRML shares per EUR share. Based on the prevailing CRML VWAP at the announcement date, the maximum 0.045 ratio would currently apply, representing an increase of about 28.6% over the previous ratio.

What Comes Next

With Lycopodium entering FY27 with stronger earnings expectations, European Lithium progressing its proposed merger and Macmahon reporting changes to director-linked holdings, investor attention could remain firmly on the mining and resources space as further company updates emerge.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise. 

 

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au